From one link: CBD has a significant therapeutic effect for epilepsy (SMD − 0.5[CI − 0.62, − 0.38] high grade) and Parkinsonism (− 0.41[CI − 0.75, − 0.08] moderate grade).

The other link is about Phase II clinical trials, i.e. ongoing research.

The point stands that there is as of yet insufficient research done to say that CBD is a fit medicine for anxiety/depression. That nature link literally says: "Evidence suggests cannabidiol (CBD) has anxiolytic properties, indicating potential for novel treatment strategies."

Suggests. Potential.

Dude, did you even read your own sources?

"...few clinical trials of CBD-based products have been conducted, and none thus far have examined the impact of these products on cognition."

"Results provide preliminary evidence supporting efficacy and tolerability of a full-spectrum, high-CBD product for anxiety...A definitive assessment of the impact of this novel treatment on clinical symptoms and cognition will be ascertained in the ongoing double-blind, placebo-controlled stage."

This paper was just published a few months ago as well. The rigorous study of CBD is still very young. Due to the War on Drugs, there have been very few well-designed late phase clinical trials for CBD.